{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:41:17Z","timestamp":1787838077084,"version":"build-2784847793"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":3096,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1016\/j.jacc.2004.11.051","type":"journal-article","created":{"date-parts":[[2005,3,11]],"date-time":"2005-03-11T16:20:28Z","timestamp":1110558028000},"page":"838-845","source":"Crossref","is-referenced-by-count":86,"title":["Long-term cost-effectiveness of clopidogrel given for up to one year in patients with acute coronary syndromes without ST-segment elevation"],"prefix":"10.1016","volume":"45","author":[{"given":"William S.","family":"Weintraub","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Mahoney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Lamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Culler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Caro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim","family":"Yusuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2004.11.051_bib1","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2004.11.051_bib2","first-page":"II758","article-title":"The cost-effectiveness of the use of clopidogrel in acute coronary syndromes based upon the CURE study","volume":"106","author":"Lamy","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2004.11.051_bib3","series-title":"Cost-Effectiveness in Health and Medicine","author":"Gold","year":"1996"},{"key":"10.1016\/j.jacc.2004.11.051_bib4","series-title":"Methods for the economic evaluation of health care programmes","author":"Drummond","year":"1987"},{"key":"10.1016\/j.jacc.2004.11.051_bib5","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1161\/01.CIR.93.10.1796","article-title":"Cholesterol lowering and the use of healthcare resources","volume":"93","author":"Pedersen","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2004.11.051_bib6","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1056\/NEJM199701303360503","article-title":"Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease","volume":"336","author":"Johannesson","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2004.11.051_bib7","unstructured":"Centers for Medicare and Medicaid Services. Medicare Part A. Available at: www.cms.gov\/statistics\/medpar\/shtstay01drg.pdf. Accessed January 10, 2005."},{"key":"10.1016\/j.jacc.2004.11.051_bib8","series-title":"DRG Guide: Descriptions and Normative Values","year":"1994"},{"key":"10.1016\/j.jacc.2004.11.051_bib9","unstructured":"Mitchell J, Burge R, Lee A, et al. Per case prospective payment for episodes of hospital care. Springfield, VA: U.S. Department of Commerce National Technical Information Service, 1995."},{"key":"10.1016\/j.jacc.2004.11.051_bib10","series-title":"Chartbook on Trends in the Health of Americans","author":"Fried","year":"2003"},{"key":"10.1016\/j.jacc.2004.11.051_bib11","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1053\/euhj.2001.2838","article-title":"A cardiovascular life history","volume":"23","author":"Peeters","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2004.11.051_bib12","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1001\/jama.288.15.1851","article-title":"Cost and cost-effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non\u2013ST-segment elevation myocardial infarction","volume":"288","author":"Mahoney","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2004.11.051_bib13","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1524-4733.2004.75013.x","article-title":"Estimating survival for cost-effectiveness analysis: a case study in atherothrombosis","volume":"7","author":"Caro","year":"2004","journal-title":"Value Health"},{"issue":"Suppl A","key":"10.1016\/j.jacc.2004.11.051_bib14","doi-asserted-by":"crossref","first-page":"425A","DOI":"10.1016\/S0735-1097(04)91792-5","article-title":"Estimating life-years lost due to atherothrombotic events: flexible survival functions to use in disease modeling","volume":"43","author":"Caro","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2004.11.051_bib15","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1093\/oxfordjournals.aje.a008670","article-title":"Adjusting survival curves for confounders: a review and a new method","volume":"143","author":"Nieto","year":"1996","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jacc.2004.11.051_bib16","first-page":"23","article-title":"Covariance adjustment of survival curves based on Cox's proportional hazards regression model","volume":"8","author":"Lee","year":"1992","journal-title":"Comput Appl Biosci"},{"key":"10.1016\/j.jacc.2004.11.051_bib17","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0021-9681(82)90058-3","article-title":"Adjusted survival curve estimation using covariates","volume":"35","author":"Makuch","year":"1982","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.jacc.2004.11.051_bib18","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1001\/jama.286.12.1494","article-title":"Comparison of 2 methods for calculating adjusted survival curves from proportional hazards models","volume":"286","author":"Ghali","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2004.11.051_bib19","series-title":"An Introduction to the Bootstrap","author":"Efron","year":"1993"},{"key":"10.1016\/j.jacc.2004.11.051_bib20","unstructured":"Bauer C, Chapman D, Lin P, et al. The CEA registry: standardizing the methods and practices of cost-effectiveness analysis. Harvard Center for Risk Analysis. Available at: http:\/\/www.hsph.harvard.edu\/cearegistry\/. Accessed January 10, 2005."},{"key":"10.1016\/j.jacc.2004.11.051_bib21","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1161\/01.CIR.85.5.1960","article-title":"Cost and health implications of cholesterol lowering","volume":"85","author":"Goldman","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2004.11.051_bib22","first-page":"927","article-title":"Tentative guidelines for using clinical and economic evaluations revisited","volume":"148","author":"Laupacis","year":"1993","journal-title":"CMAJ"},{"key":"10.1016\/j.jacc.2004.11.051_bib23","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1001\/jama.1991.03470010097038","article-title":"Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials","volume":"266","author":"Yusuf","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2004.11.051_bib24","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1161\/01.CIR.0000051362.96946.15","article-title":"Early and late effects of clopidogrel in patients with acute coronary syndromes","volume":"107","author":"Yusuf","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2004.11.051_bib25","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","article-title":"Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study","volume":"358","author":"Mehta","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2004.11.051_bib26","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.288.19.2411","article-title":"Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial","volume":"288","author":"Steinhubl","year":"2002","journal-title":"JAMA"},{"issue":"Suppl A","key":"10.1016\/j.jacc.2004.11.051_bib27","doi-asserted-by":"crossref","first-page":"540A","DOI":"10.1016\/S0735-1097(03)82885-1","article-title":"Modeling the cost-effectiveness of clopidogrel in acute coronary syndromes without ST-segment elevation in Sweden","volume":"41","author":"Lindgren","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2004.11.051_bib28","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1056\/NEJM200206063462309","article-title":"Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease","volume":"346","author":"Gaspoz","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2004.11.051_bib29","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S0735-1097(02)02119-8","article-title":"Prospective analysis of creatine kinase muscle-brain fraction and comparison with troponin T to predict cardiac risk and benefit of an invasive strategy in patients with non\u2013ST-elevation acute coronary syndromes","volume":"40","author":"Kleiman","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2004.11.051_bib30","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0002-8703(03)00095-4","article-title":"Prognostic implication of creatine kinase release after elective percutaneous coronary intervention in the pre-IIb\/IIIa antagonist era","volume":"145","author":"Ghazzal","year":"2003","journal-title":"Am Heart J"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109704024957?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109704024957?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T05:57:08Z","timestamp":1548655028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109704024957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S0735109704024957"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2004.11.051","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]}}}